Michel Baijot – Biography
Last update: May 2, 2026Executive profile
Michel was Worldwide Vice President Strategy, Licensing & M&A at GSK Vaccines, and Chief Business Officer at Janssen Crucell Vaccines. Michel Baijot joined 20Med Therapeutics in 2026.
Michel Baijot is currentlyChairman of the Board at 20Med Therapeutics - View - 20Med Therapeutics org chart
Director at Expres2ion Biotech - View - Expres2ion Biotech org chart
Create your alert
to follow the career of Michel Baijot.
Education
Michel Baijot has a PhD in molecular biology from University of Louvain.
More about Michel Baijot
Selected links
Do you need to know more about Michel Baijot? More results.
Participate
Social media
- Michel Baijot on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Michel Baijot
The colleagues of Michel Baijot
Company Colleagues
- At 20Med Therapeutics, Michel Baijot has 5 colleagues including Michiel Lodder (CEO), Tom Schwarz (Director)…
- At Expres2ion Biotech, Michel Baijot has 8 colleagues including Bent Frandsen (CEO), Jakob Knudsen (Director)…
Industry Colleagues
- In the Biotechnology industry, Michel Baijot has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Michel Baijot.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Michel Baijot.
